• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    High Tide Secures Credit Approval for C$40MM of Senior Secured Credit Facilities

    6/15/26 6:15:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary
    Get the next $HITI alert in real time by email

    CALGARY, AB, June 15, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that, further to its press release dated May 5, 2026, it has secured credit approval for a loan agreement (the "Loan Agreement") with Bank of Montreal ("BMO") in respect of new senior secured credit facilities in the principal amount of C$40 million (the "New Credit Facilities"). Closing of the New Credit Facilities remains subject to the satisfaction of customary closing conditions. Upon closing, the New Credit Facilities will replace the Company's existing senior credit facility.

    High Tide Inc., June 15, 2026

    "This is a defining moment for High Tide and speaks volumes about the scale, consistency, and quality of what we have built. Our new senior lender's facility translates directly into materially lower-cost capital as we enter our next phase of growth," said Raj Grover, Founder and Chief Executive Officer of High Tide.

    TRANSACTION DETAILS

    The Loan Agreement provides for two committed facilities, on terms consistent with those announced by the Company on May 5, 2026:

    • A $25 million committed revolving facility with a three-year maturity, to be used to refinance the Company's loan with connectFirst at closing, for general working capital and corporate requirements, and for permitted acquisitions and permitted investments. The balance owing to connectFirst is expected to be slightly over $6 million at closing, resulting in almost $19 million of available room on the revolving facility.
    • A $15 million committed delayed draw term loan to be used to refinance the Company's existing $15 million second-lien debentures.

    Funds under the New Credit Facilities will become available to the Company, following the satisfaction of customary closing conditions, at which time the Company's existing senior credit facility will be repaid. The Company will provide a further update upon closing expected within approximately 30 days.

    ABOUT HIGH TIDE

    High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

    Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 228 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.

    Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

    High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

    Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

    CONTACT INFORMATION

    Media Inquiries

    Omar Khan

    Chief Communications and Public Affairs Officer

    High Tide Inc.

    omar@hightideinc.com

    403-770-3080

    Investor Inquiries

    Vahan Ajamian

    Capital Markets Advisor

    High Tide Inc.

    vahan@hightideinc.com 

    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

    This press release may contain "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the closing of the New Credit Facilities and the satisfaction of customary closing conditions; the timing of closing; the repayment of the Company's existing senior credit facility; the use of proceeds from the New Credit Facilities being utilized as outlined herein; the expected balance owing to its existing senior lender at closing and the resulting availability under the revolving facility; the ability of the Company to comply with the financial covenants; the anticipated effects of the New Credit Facilities on the business and operations of High Tide; and the ability of the Company to pursue accretive growth across its retail network, scale its German platform through Remexian, and expand into other federally legal markets.

    Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

    High Tide Inc. Logo

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-secures-credit-approval-for-c40mm-of-senior-secured-credit-facilities-302799870.html

    SOURCE High Tide Inc.

    Get the next $HITI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HITI

    DatePrice TargetRatingAnalyst
    2/22/2022$7.75 → $7.25Neutral
    Cantor Fitzgerald
    12/10/2021$8.75 → $7.75Neutral
    Cantor Fitzgerald
    11/23/2021Neutral
    Cantor Fitzgerald
    11/23/2021$8.75Neutral
    Cantor Fitzgerald
    9/13/2021$12.00Buy
    ROTH Capital
    9/3/2021Buy
    Desjardins
    9/3/2021$15.00Buy
    Desjardins
    More analyst ratings

    $HITI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

    CALGARY, AB, June 17, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its majority-owned subsidiary, Remexian Pharma GmbH ("Remexian"), showcased its exclusive German medical cannabis distribution partnerships with leading Canadian cannabis brands at Mary Jane Berlin 2026, one of Europe's largest cannabis trade shows, held June 11–14, 2026, in Berlin, Germany. Through these partnerships, Remexian is bringing premium Canadian medical cannabis products to German patients and pharmacies, further strengthening its

    6/17/26 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

    The Company Also Reports Positive Free Cash Flow and Net IncomeThe Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive GrowthCanadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous YearELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,1 and Continues to Hold a Leading 12% Share of the Cannabis

    6/15/26 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Secures Credit Approval for C$40MM of Senior Secured Credit Facilities

    CALGARY, AB, June 15, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that, further to its press release dated May 5, 2026, it has secured credit approval for a loan agreement (the "Loan Agreement") with Bank of Montreal ("BMO") in respect of new senior secured credit facilities in the principal amount of C$40 million (the "New Credit Facilities"). Closing of the New Credit Facilities remains subject to the satisfaction of customary closing conditions. Upon closing, the New Credit Facilities will replace the

    6/15/26 6:15:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald reiterated coverage on High Tide with a new price target

    Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.25 from $7.75 previously

    2/22/22 6:03:19 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Cantor Fitzgerald reiterated coverage on High Tide with a new price target

    Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.75 from $8.75 previously

    12/10/21 5:41:48 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Cantor Fitzgerald initiated coverage on High Tide

    Cantor Fitzgerald initiated coverage of High Tide with a rating of Neutral

    11/23/21 7:32:46 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    SEC Filings

    View All

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    6/17/26 7:50:30 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    6/15/26 4:46:21 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    6/15/26 4:03:10 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Financials

    Live finance-specific insights

    View All

    High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

    The Company Also Reports Positive Free Cash Flow and Net IncomeThe Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive GrowthCanadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous YearELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,1 and Continues to Hold a Leading 12% Share of the Cannabis

    6/15/26 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Reports First Quarter 2026 Financial Results Featuring Record Revenue Exceeding $700 Million Annualized

    Canna Cabana Remains the Largest Cannabis Retailer in Canada with 220 Current Locations The Company Reiterates its Long-Term Goal to Exceed 350 Locations Across CanadaThe Company Generated $2.9 Million in Free Cash Flow During the Quarter, Marking Significant Improvements Year Over Year and Sequentially. Over the Past 12 Months, the Company Has Generated $16.8 Million in Free Cash FlowCanadian Cabana Club Members Now Exceed 2.58 Million, Up 47% Year Over Year, Marking the Fastest Pace in 10 Quarters and Remains the Largest Cannabis Loyalty Program GloballyELITE Members in Canada Have Surpassed 162,000, Up 100% Year Over YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Re

    3/17/26 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Reports Fourth Quarter and 2025 Year End Financial Results Featuring Record Revenue and Adjusted EBITDA

    The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market Canadian Cabana Club Members Now Exceed 2.5 Million, Up 45% Year Over Year, Marking the Fastest Pace in Four Quarters ELITE Members in Canada Have Surpassed 151,000, Once Again Growing at the Fastest Rate Since Inception In Fiscal 2025, Same-Store Sales Were Up 4.1%. For the Fourth Fiscal Quarter, Same-Store Sales Rose 5.5% Year Over YearThe Company Opened 27 New Canna Cabana Locations Organically in Calendar 2025, Achieving the Higher End of Its Communicated Goal, and Remains the Largest Cannabis Retailer in Canada with 21

    1/29/26 4:01:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $HITI
    Leadership Updates

    Live Leadership Updates

    View All

    High Tide and NuLeaf Naturals Join U.S. National Compassionate Care Council as Founding Members

    CALGARY, AB, March 4, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, and its leading U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, today announced they have joined the National Compassionate Care Council (NCCC) as founding members. "Federal cannabis policy in the United States is entering a meaningful transition," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Through our experience building

    3/4/26 10:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Announces Appointment of Two New Directors, and Appointment of Two Advisors with Focus on Real Estate and Artificial Intelligence

    CALGARY, AB, March 3, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today changes to its Board of Directors (the "Board") as part of a planned board renewal process. Board TransitionsThe Company announces that Nitin Kaushal and Andrea Elliott have resigned from the Board, effective March 2, 2026. On behalf of the Board and management, the Company thanks Mr. Kaushal, on the board since 2018, and Ms. Elliott,

    3/3/26 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH

    Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase

    8/14/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary